Companies / Antares Pharma, Inc.
Antares Pharma, Inc.
ATRSCIK 1016169
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 24, 2022 | Apple Robert F Executive | Other Sold to issuer | Common Stock | $10.51M | -1.9M -100.00% | 0 | low |
| May 24, 2022 | Apple Robert F Executive | Other Sold to issuer | Common Stock | $3.43M | -612K -100.00% | 0 | low |
| May 24, 2022 | Powell Fred M Executive | Other Sold to issuer | Common Stock | $3.29M | -587K -100.00% | 0 | low |
| May 24, 2022 | Graham Peter J Executive | Other Sold to issuer | Common Stock | $2.32M | -414K -100.00% | 0 | low |
| May 24, 2022 | Gueth Anton Director | Other Sold to issuer | Common Stock | $2.16M | -386K -100.00% | 0 | low |
| May 24, 2022 | Apple Robert F Executive | Other Sold to issuer | Common Stock | $2.09M | -374K -100.00% | 0 | low |
| May 24, 2022 | Garrity Thomas J Director | Other Sold to issuer | Common Stock | $1.26M | -224K -100.00% | 0 | low |
| Feb 18, 2021 | Apple Robert F Executive | Sell Open-market sale | Common Stock | $1.21M | -242K -9.89% | 2,204,760 | medium |